Haematologica Reports 2006; 2: issue 5
Bortezomib (Velcade®) in multiple myeloma: an update
Bortezomib: introduction
Alessandro Corso
An update of the apex study
Alessandro Corso
Bortezomib-combination based therapy in relapsed-refractory myeloma patients
Patrizia Zappasodi
Bortezomib in newly diagnosed multiple myeloma patients
Silvia Mangiacavalli
Frequency and characteristics of hematologic and non-hematologic Bortezomib-related toxicity
Marzia Varettoni